CTLA4 and neoplasm: However, the advantage of Pulsed radiation + anti-CTLA-4 over one cycle of XRT + anti-CTLA-4 group on the secondary tumor growth was not as evident as the primary tumor (Parental: p = 0.0548, Resistant: p < 0.0001) (Figures 3C, D).